De-Novo Low TAC/Low SIR Immunosuppression after HTx-10 Year Results of a Prospective Trial

K. Stroeh,S. Guethoff, C. Grinninger,B. Meiser,C. Hagl,I. Kaczmarek

Journal of Heart and Lung Transplantation（2014）

引用 0|浏览12

暂无评分

摘要

s S15 Conclusion: This was the first study to demonstrate a lower rate of CMV infection in patients treated with Tac vs. those treated with CsA after HTx.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要